Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.93 | 0.50 | 0.84 | 0.60 | 3.96 | 5.30 | 20.86 | 22.35 | 36.36 | 48.40 | 25.19 | 36.91 |
| Expenses | 1.04 | 0.61 | 0.69 | 1.04 | 3.74 | 5.17 | 20.63 | 22.17 | 35.66 | 47.09 | 23.91 | 35.60 |
| Operating Profit | -0.11 | -0.11 | 0.15 | -0.44 | 0.22 | 0.13 | 0.23 | 0.18 | 0.70 | 1.31 | 1.28 | 1.31 |
| OPM % | -11.83% | -22.00% | 17.86% | -73.33% | 5.56% | 2.45% | 1.10% | 0.81% | 1.93% | 2.71% | 5.08% | 3.55% |
| Other Income | 0.05 | 0.09 | 0.13 | 0.10 | -0.08 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.03 | 0.05 | 0.07 |
| Profit before tax | -0.07 | -0.03 | 0.27 | -0.34 | 0.14 | 0.13 | 0.21 | 0.17 | 0.72 | 1.28 | 1.23 | 1.12 |
| Tax % | 0.00% | 0.00% | 0.00% | 2.94% | 0.00% | -15.38% | 14.29% | 41.18% | 26.39% | 21.88% | 26.02% | -5.36% |
| Net Profit | -0.07 | -0.03 | 0.28 | -0.35 | 0.13 | 0.15 | 0.18 | 0.11 | 0.53 | 1.00 | 0.91 | 1.18 |
| EPS in Rs | -0.09 | -0.04 | 0.35 | -0.35 | 0.13 | 0.15 | 0.18 | 0.09 | 0.37 | 0.58 | 0.43 | 0.49 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1 | 4 | 3 | 4 | 2 | 1 | 1 | 2 | 4 | 31 | 132 | 147 |
| Expenses | 1 | 3 | 3 | 3 | 1 | 4 | 3 | 2 | 4 | 31 | 129 | 142 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | -3 | -2 | 0 | -0 | 0 | 4 | 5 |
| OPM % | 43% | 5% | 15% | 6% | 12% | -244% | -151% | 0.0% | -6% | 0.5% | 2.7% | 3.1% |
| Other Income | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | -3 | -2 | -0 | 0 | 0 | 3 | 4 |
| Tax % | 31% | 24% | 34% | -32% | 20% | 0% | -1% | 0% | 50% | 33% | 25% | |
| Net Profit | 0 | 0 | 0 | 0 | 0 | -3 | -2 | -0 | 0 | 0 | 3 | 4 |
| EPS in Rs | 0.12 | 0.19 | 0.22 | 0.31 | 0.11 | -4.04 | -1.93 | -0.07 | 0.01 | 0.08 | 1.21 | 1.87 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 63% | 152% | 310% | 180% | ||
| Compounded Profit Growth | 40% | 23% | 255% | 535% | ||
| Stock Price CAGR | 26% | 66% | 98% | 75% | ||
| Return on Equity | -1% | 2% | 5% | 8% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 10 | 21 |
| Reserves | 3 | 3 | 3 | 4 | 4 | 4 | 1 | -1 | -1 | -1 | 8 | 25 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 46 |
| Total Liabilities | 12 | 12 | 12 | 12 | 12 | 12 | 9 | 7 | 7 | 7 | 27 | 92 |
| Fixed Assets | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 3 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 3 | 2 | 3 | 3 | 4 | 4 | 1 | 3 | 3 | 0 | 0 |
| Other Assets | 9 | 8 | 9 | 9 | 9 | 8 | 5 | 5 | 4 | 4 | 27 | 89 |
| Total Assets | 12 | 12 | 12 | 12 | 12 | 12 | 9 | 7 | 7 | 7 | 27 | 92 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0 | 2 | -1 | 1 | -0 | 1 | 1 | 1 | -2 | -0 | -14 | -22 |
| Cash from Investing Activity | -0 | -2 | 1 | -1 | 0 | -0 | 0 | 0 | 0 | 0 | 3 | -2 |
| Cash from Financing Activity | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 26 |
| Net Cash Flow | -1 | 0 | -0 | -0 | 0 | 1 | 1 | 1 | -2 | -0 | 1 | 2 |
| Free Cash Flow | -1 | 2 | -1 | 1 | -0 | 1 | 0 | -1 | -2 | -0 | -14 | -26 |
| CFO/OP | -90% | 472% | -535% | 225% | -220% | 672% | -18% | -34% | 136% | -9,771% | -631% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 30 | 4 | 40 | 130 | 216 | 19 | 25 | 32 | 36 | 1 | 216 | 163 |
| Inventory Days | 0 | 28 | 19 | 13 | 39 | 89 | 239 | 222 | 113 | 10 | 42 | |
| Days Payable | 0 | 54 | 13 | 5 | 4 | 0 | 14 | 0 | 114 | 116 | ||
| Cash Conversion Cycle | 30 | 4 | 68 | 95 | 216 | 54 | 111 | 271 | 244 | 114 | 112 | 88 |
| Working Capital Days | 2,225 | 2,584 | 863 | 932 | 858 | 1,711 | 819 | 647 | 743 | 346 | 197 | 110 |
| ROCE % | 1% | 1% | 1% | 3% | 1% | 1% | -31% | -19% | -1% | 0% | 1% | 11% |
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jul 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.92% | 66.92% | 66.54% | 66.56% | 66.56% | 66.56% | 52.75% | 53.33% | 51.97% | 49.43% | 50.57% | 54.29% |
| Public | 33.08% | 33.08% | 33.46% | 33.44% | 33.45% | 33.44% | 47.25% | 46.66% | 48.01% | 50.57% | 49.43% | 45.69% |
| No. of Shareholders | 2,621 | 2,635 | 2,569 | 2,533 | 2,502 | 2,484 | 2,408 | 2,697 | 2,994 | 2,975 | 3,118 | 3,127 |
Fundamentals
Market Cap₹ 199 Cr.
Current Price₹ 70.0
Stock P/E55.1
Book Value₹ 22.0
ROCE10.9 %
ROE8.00 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)180%
Compounded Profit Growth (TTM)535%
Standalone figures.
Valuation
Market capRs 148 Cr
Enterprise valueRs 145 Cr
P/E (TTM)40.77x
Price to book3.17x
Price to sales1.00x
EV / EBITDA31.58x
EV / EBIT32.72x
EV / sales0.98x
Earnings yield2.45%
P/E, 3-year average589.76x
P/B, 3-year average1.98x
P/E, 5-year average589.76x
P/B, 5-year average1.59x
Profitability
Operating margin (excl. other income)2.68%
Operating margin (incl. other income)2.71%
EBITDA margin3.12%
Pre-tax margin2.96%
Net profit margin2.46%
Net margin, latest quarter3.20%
ROE8.00%
ROCE10.87%
ROA4.28%
ROE, 3-year average2.93%
ROCE, 3-year average4.04%
ROA, 3-year average1.63%
ROE, 5-year average-2.30%
ROCE, 5-year average-1.63%
ROA, 5-year average-3.07%
ROIC (approx.)7.62%
Tax rate24.93%
Other income / net worth0.06%
Growth
Sales growth (latest year)330.70%
Profit growth (latest year)3100.00%
Sales CAGR, 3 years309.98%
Sales CAGR, 5 years151.69%
Sales growth QoQ46.53%
Profit growth QoQ29.67%
Sales growth YoY (latest quarter)65.15%
Profit growth YoY (latest quarter)972.73%
Per share
EPS (TTM)Rs 1.72
EPS (latest year)Rs 1.21
EPS (latest quarter)Rs 0.56
EPS, 3-year averageRs 0.44
EPS, 5-year averageRs -0.14
Book value per shareRs 22.05
Sales per shareRs 69.65
Cash flow per shareRs -10.62
Free cash flow per shareRs -12.33
Efficiency
Asset turnover1.43x
Fixed asset turnover38.46x
Inventory turnover8.80x
Inventory days41 days
Debtor days163 days
Debtors turnover2.24x
Creditor days116 days
Cash conversion cycle88 days
Working capital days110 days
Leverage
Cash and bankRs 3 Cr
Net debtRs -3 Cr
Net debt / EBITDA-0.65x
Interest coverage63.14x
Owners' fund to total sources50.30%
Cash flow
Cash from Operating Activity (latest year)Rs -22 Cr
Cash from Investing Activity (latest year)Rs -2 Cr
Cash from Financing Activity (latest year)Rs 26 Cr
Net Cash Flow (latest year)Rs 2 Cr
Free cash flow (latest year)Rs -26 Cr
Cash from ops / profit, 5 years-37.00x
Statement figures
Net sales (TTM)Rs 147 Cr
Net sales (latest year)Rs 132 Cr
Sales (latest quarter)Rs 37 Cr
Operating profit excl. other income (latest year)Rs 4 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 5 Cr
PBDT (TTM)Rs 5 Cr
Profit before tax (TTM)Rs 4 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 4 Cr
Net profit (latest year)Rs 3 Cr
Net profit (latest quarter)Rs 1 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 127 Cr
Total expenditure (latest year)Rs 129 Cr
Total income (latest year)Rs 132 Cr
Share capitalRs 21 Cr
ReservesRs 25 Cr
Shareholders' fundsRs 46 Cr
Total assetsRs 92 Cr
Net blockRs 3 Cr
InvestmentsRs 0 Cr
ReceivablesRs 59 Cr
InventoryRs 14 Cr
Other liabilitiesRs 46 Cr
Shares outstanding (crore)2.11
Ownership
Promoter holding54.29% (+0.96 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 40.8 is at the 18th percentile of its own 4.8-year range
(median 98.7, low 16.4, high 267.2).
P/B 3.17 is at the 68th percentile (median 2.27).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 536565 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -0.7% | -2.8% | +2.1 pts |
| 1 month | -13.0% | -6.8% | -6.3 pts |
| 3 months | -8.9% | -7.6% | -1.3 pts |
| 3 years | +671.8% | +14.2% | +657.6 pts |
| 5 years | +1159.0% | +27.9% | +1131.1 pts |
Red flags
F-score 5 of 8| explain | Weak cash conversion Cash from operations was -1374% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 27% of total assets in 2026 |
| explain | Share dilution Share count up 111% in a year, 160% in three |
| look | Inventory outrunning sales Inventory grew 1618% vs sales +331% in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹37 Cr +65.1% vs Jun 2025.
Net profit ₹1 Cr +972.7%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Syngene International Ltd | 14,823 | 50.0 | 9.99 % |
| Indegene Ltd | 14,580 | 35.0 | 18.8 % |
| Suven Life Sciences Ltd | 9,176 | -79.5 % | |
| Vimta Labs Ltd | 2,642 | 32.7 | 25.2 % |
| Fabtech Technologies Ltd | 661 | 13.6 | 13.6 % |
| Bilcare Ltd | 229 | 11.5 | 7.06 % |
| Take Ltd | 208 | 35.2 | 18.5 % |
| Jeevan Scientific Technology Ltd | 163 | 46.7 | 5.01 % |
| Adeshwar Meditex Ltd | 24 | 19.4 | 5.21 % |
| Vanta Bioscience Ltd | 15 | 133 | 1.19 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Novelix Pharmaceuticals Ltd?
Novelix Pharmaceuticals Ltd (536565) has a market capitalisation of Rs 199 Cr. at the 2026-10-01 close.
What is the P/E ratio of Novelix Pharmaceuticals Ltd?
Novelix Pharmaceuticals Ltd trades at a P/E of 55.1 on trailing twelve-month profit, at the 2026-10-01 close.
What were Novelix Pharmaceuticals Ltd's latest quarterly results?
In the Jun 2026 quarter, Novelix Pharmaceuticals Ltd sales was Rs 37 Cr (+65.1% vs Jun 2025) and net profit was Rs 1 Cr.